A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
Completed
Shire
Phase 3
2002-10-14
The purpose of this study is to assess the safety of lanthanum carbonate in patients
undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to
continue treatment.
Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
Completed
Shire
Phase 3
2004-02-09
The purpose of this study is to test how well higher doses of lanthanum carbonate reduce the
pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal
disease.
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
Completed
Shire
Phase 3
2005-01-07
The purpose of this study is to assess phosphate reduction and control in patients with End
Stage Renal Disease treated with either lanthanum carbonate or sevelamer hydrochloride
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Completed
Shire
Phase 4
2005-01-10
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis
level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and
to determine the patient and physician's satisfaction.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
